These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19249632)

  • 1. Prenatal screening for Down's syndrome: balanced debate needed.
    Summerfield P
    Lancet; 2009 Feb; 373(9665):722. PubMed ID: 19249632
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethnic differences in informed decision-making about prenatal screening for Down's syndrome.
    Fransen MP; Essink-Bot ML; Vogel I; Mackenbach JP; Steegers EA; Wildschut HI
    J Epidemiol Community Health; 2010 Mar; 64(3):262-8. PubMed ID: 19692718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum screening for Down's syndrome. Creates stress for carers and parents.
    Bunn A; Forrest K; Ioannou G; Rea R
    BMJ; 1996 Apr; 312(7036):974-5. PubMed ID: 8616326
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study.
    Hall S; Bobrow M; Marteau TM
    BMJ; 2000 Feb; 320(7232):407-12. PubMed ID: 10669444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ethical aspects of prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2000 Oct; 141(42):2293-8. PubMed ID: 11076495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Notifying parents of Down's syndrome: the experiences of parents].
    Lantrès A
    Soins Pediatr Pueric; 2011; (263):36-8. PubMed ID: 22288264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis work-up in prenatal medicine: the example of Down's syndrome].
    Shojai R; Boubli L; d'Ercole C
    Gynecol Obstet Fertil; 2005; 33(7-8):514-9. PubMed ID: 16005658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for Down's syndrome--a search for the family's values.
    Copel JA; Bahado-Singh RO
    N Engl J Med; 1999 Aug; 341(7):521-2. PubMed ID: 10441609
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal screening, ethics and Down's syndrome: a literature review.
    Alderson P
    Nurs Ethics; 2001 Jul; 8(4):360-74. PubMed ID: 16004090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undergoing prenatal screening for Down's syndrome: presentation of choice and information in Europe and Asia.
    Hall S; Chitty L; Dormandy E; Hollywood A; Wildschut HI; Fortuny A; Masturzo B; Santavý J; Kabra M; Ma R; Marteau TM
    Eur J Hum Genet; 2007 May; 15(5):563-9. PubMed ID: 17311082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 14. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic and socio-economic differences in uptake of prenatal diagnostic tests for Down's syndrome.
    Fransen MP; Wildschut HI; Mackenbach JP; Steegers EA; Galjaard RJ; Essink-Bot ML
    Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):158-62. PubMed ID: 20546988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
    Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum screening.
    Klein MC
    CMAJ; 1999 Apr; 160(8):1125; author reply 1125-6. PubMed ID: 10234333
    [No Abstract]   [Full Text] [Related]  

  • 19. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
    Wald NJ; Huttly W; Hackshaw AK
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12411371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.